Renowned luminaries in Personalized Medicine
Groundbreaking companies with emerging technologies
More than 1000 peers from around the globe
50 sessions in 3 parallel tracks


Personalized Medicine in Organ Transplantation



John Sninsky, Ph.D., Chief Scientific Officer, CareDx Inc.

John Sninsky, Ph.D. joined CareDx Inc. as Chief Scientific Officer in January 2015. CareDx, Inc., based in Brisbane, California, is a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value, non-invasive diagnostic surveillance solutions for transplant recipients. Read Full Bio

Roy First, M.D., Chief Medical Officer, Transplant Genomics, Inc.

Roy First, M.D. is Chief Medical Officer at Transplant Genomics, Inc. Previously he was VP and Global Therapeutic Leader (Transplantation) at Astellas Pharma, and Medical Director of Kidney Transplantation at the University of Cincinnati. Read Full Bio

Minnie Sarwal, M.D., Ph.D., Professor of Surgery and Director of the Translational Transplant Research Program, UCSF

Minnie Sarwal has over 30 years of clinical experience and 25 years of research experience in translational immunogenetics, genomics, proteomics and informatics. She holds a PhD in Molecular Genetics from Cambridge University, under the mentorship of Nobel Laureate Sydney Brenner. Read Full Bio

Web Analytics